Anzeige
Mehr »
Samstag, 02.05.2026 - Börsentäglich über 12.000 News
Mit Graphen gegen jede Abwehr - Die Zukunft der Drohnen ist da
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von pharmaphorum

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
21.04.Italy leads the way on child genetic disease diagnosis
20.04.Update: Lilly makes $7bn bid for in vivo CAR-T firm Kelonia
20.04.UK Knowledge Quarter welcomes Boehringer Ingelheim AI accelerator
20.04.Lilly said to be readying $2bn-plus bid for Kelonia
20.04.AZ is three for three with COPD hope tozorakimab
20.04.UCB cuts $1.15bn deal to buy epilepsy biotech Neurona
17.04.Obesity biotech Kailera's record-breaking IPO
17.04.OpenAI introduces GPT-Rosalind, its drug discovery AI
17.04.Multiple myeloma drug Blenrep backed for wider NHS use
17.04.Trump names Erica Schwartz to fill leadership void at CDC
16.04.UK says it has hit target on commercial trial set-up times
16.04.Lift for UK healthtech as fund bags £100m from national bank
16.04.FDA accelerated approval path needs improvement, says ICER
16.04.Lilly says Foundayo safety confirmed in ACHIEVE-4 trial
16.04.Beeline raises $300m for BMS drugs, and other biofinancings
16.04.Most patients "won't see benefit" with Alzheimer's drugs
15.04.Novartis CEO joins board of "responsible" AI firm Anthropic
15.04.Scientists issue call to arms over antifungal resistance
15.04.Daiichi exits OTC, with $1.55bn unit sale to Suntory
15.04.Parkinson's charity partners Biognosys on biomarker project
15.04.Amazon launches its AI drug discovery platform
15.04.FDA seeks safety data for Lilly's oral GLP-1 Foundayo
14.04.FDA renews criticism of trial sponsors over transparency
14.04.Novo Nordisk partners OpenAI on R&D "transformation"
14.04.Travere claims first FDA OK in rare kidney disease FSGS